Ergoteles LLC Standard Biotools Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.93 - $1.52 $166,077 - $271,438	-178,578 Reduced 90.7%	18,319 $21,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $166,653 - $312,096	-151,503 Reduced 43.49%	196,897 $217,000
Q2 2022 Aug 12, 2022	BUY	$1.6 - $3.99 $557,440 - $1.39 Million	348,400 New	348,400 $557,000
Q1 2022 May 13, 2022	SELL	$2.8 - $3.96 $153,854 - $217,594	-54,948 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $199,461 - $336,831	54,948 New	54,948 $215,000
Q1 2021 May 12, 2021	SELL	$3.94 - $7.09 $328,596 - $591,306	-83,400 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$5.45 - $8.65 $454,530 - $721,410	83,400 New	83,400 $500,000

142

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.